KNSA KINIKSA PHARMACEUTICALS INTERNATIONAL PLC Management Changes 8-K Filing 2024 - Board Appointment Kiniksa Pharmaceuticals appointed M. Cantey Boyd as a new director, increasing the board size from nine to ten members, and she will also serve on the Compensation Committee.Get access to all SEC 8-K filings of the KINIKSA PHARMACEUTICALS INTERNATIONAL PLC